Clinical Pharmacology of 5-Fluorouracil
- 1 April 1989
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 16 (4), 215-237
- https://doi.org/10.2165/00003088-198916040-00002
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The effect of 5-fluorouracil on DNA chain elongation in intact bone marrow cellsBiochemical and Biophysical Research Communications, 1985
- Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugsCancer Treatment Reviews, 1982
- Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetasePharmacology & Therapeutics, 1981
- The incorporation of 5-fluoro-2′-deoxyuridine into DNA of mammalian tumor cellsBiochemical and Biophysical Research Communications, 1981
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979
- Inhibition of transfer RNA function by replacement of uridine and uridine-derived nucleosides with 5-fluorouridineBiochemistry, 1978
- Antineoplastic DrugsDrugs, 1978
- Fluorouracil Therapy in Patients With Carcinoma of the Large BowelClinical Pharmacokinetics, 1978
- Combination chemotherapy: The interaction of methotrexate and 5-fluorouracilEuropean Journal of Cancer (1965), 1973
- Nucleic acid related compounds. III. Facile synthesis of 5-fluorouracil bases and nucleosides by direct fluorinationJournal of the American Chemical Society, 1971